Effects of an outreach and internal navigation program on breast cancer diagnosis in an urban cancer center with a large African‐American population
Abstract
BACKGROUND.: Compared with white women, African‐American (AA) women who are diagnosed with breast cancer experience an excess in mortality. To improve outcomes, the authors implemented community education and outreach initiatives in their cancer center, at affiliated primary care sites, and in the surrounding communities. They then assessed the effectiveness of these outreach initiatives and internal patient navigation on stage of diagnosis.METHODS.: This cross‐sectional study was an analysis of all women with breast cancer who were diagnosed and/or treated in the years from 2001 through 2004. The outreach initiatives were implemented in 2001; 125 trained Community Health Advocates (CHAs) provided educational programs to the community, and Patient Navigators communicated directly with patients to encourage screening, diagnostic procedures, and treatment.RESULTS.: In total, 487 patients were diagnosed/treated from 2001 through 2004. Since 2001, there were 1148 community interventions by CHAs with an estimated program attendance of >10,000 participants. In the interval from 2001 through 2004, the proportion of stage 0 (in situ) breast cancers increased from 12.4% (n = 14) to 25.8% (n = 33; P < .005), and there was a decline in stage IV invasive breast cancers from 16.8% (n = 19) to 9.4% (n = 12; P < .05).CONCLUSIONS.: The outreach initiatives and internal patient navigation appear to have improved stage at diagnosis. To determine whether specific patients presented earlier as a result of specific community outreach initiatives, prospective work is underway to measure the effects of these interventions on potential stage migration. Similarly, prospective data are being collected to determine whether Patient Navigators influence treatment and appointment adherence as well as the underlying reasons for barriers to specific interventions in this underserved minority population. Cancer 2008. © 2008 American Cancer Society.Keywords
This publication has 43 references indexed in Scilit:
- Dasatinib, an orally active small molecule inhibitor of both the src and abl kinases, selectively inhibits growth of basal-type/“triple-negative” breast cancer cell lines growing in vitroBreast Cancer Research and Treatment, 2007
- Race, Breast Cancer Subtypes, and Survival in the Carolina Breast Cancer StudyJAMA, 2006
- Meta-Analysis of Survival in African American and White American Patients With Breast Cancer: Ethnicity Compared With Socioeconomic StatusJournal of Clinical Oncology, 2006
- Determinants of Cancer Disparities: Barriers to Cancer Screening, Diagnosis, and TreatmentSurgical Oncology Clinics of North America, 2005
- African‐American/White differences in breast carcinomaCancer, 2004
- Racial disparities in breast carcinoma survival ratesCancer, 2003
- Treatment choices and response rates in African-American women with breast carcinomaCancer, 2002
- Mammography screening and breast cancer biology in African American women—a reviewCancer Detection Prevention, 2002
- The biology and natural history of breast cancer from the screening perspectiveWorld Journal of Surgery, 1989
- Analysis of survival and recurrence vs. patient and doctor delay in treatment of breast cancerCancer, 1975